SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
SGLT2 inhibitors may be more cardioprotective for older adults, whereas GLP-1 receptor agonists may confer greater HbA1c reductions in that population. Image: Adobe Stock “Age should not be a ...
Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah School of Medicine, Salt Lake City, Utah 84112, United States Nora Eccles Harrison Cardiovascular Research and ...
Menopause significantly increases the risk of cardiovascular diseases in women due to a drop in estrogen levels.
With early diagnosis and the right treatment, women with endometriosis can manage their condition effectively, reducing the ...
Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...
HealthDay on MSN5 天
Age Differences Seen in Efficacy of Type 2 Diabetes TreatmentsHealthDay News — Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in the Journal of the American Medical Association.
One of the easiest things you can do is to eliminate (or strictly limit) certain foods that are especially hard on your heart ...
Among the many plant-based proteins you can add to your diet, one underrated food is good for your blood pressure. Research ...
According to an American longevity expert there is almost no dementia among Ikaria's residents and tea and coffee may help ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果